EARNEST Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-61	Closed	-$10.8K	–	324
2023 Q3	$10.8K	Hold	61	–	–	﹤0.01%	618
2023 Q2	$11.6K	Hold	61	–	–	﹤0.01%	599
2023 Q1	$12.2K	Hold	61	–	–	﹤0.01%	582
2022 Q4	$14.5K	Hold	61	–	–	﹤0.01%	539
2022 Q3	$12K	Hold	61	–	–	﹤0.01%	544
2022 Q2	$9K	Hold	61	–	–	﹤0.01%	613
2022 Q1	$10K	Hold	61	–	–	﹤0.01%	635
2021 Q4	$10K	Hold	61	–	–	﹤0.01%	664
2021 Q3	$12K	Hold	61	–	–	﹤0.01%	593
2021 Q2	$10K	Hold	61	–	–	﹤0.01%	645
2021 Q1	$9K	Hold	61	–	–	﹤0.01%	654
2020 Q4	$8K	Hold	61	–	–	﹤0.01%	665
2020 Q3	$9K	Hold	61	–	–	﹤0.01%	581
2020 Q2	$9K	Buy	61 +34	+126%	+$5.02K	﹤0.01%	580
2020 Q1	$3K	Hold	27	–	–	﹤0.01%	774
2019 Q4	$3K	Hold	27	–	–	﹤0.01%	897
2019 Q3	$2K	Hold	27	–	–	﹤0.01%	956
2019 Q2	$2K	Hold	27	–	–	﹤0.01%	971
2019 Q1	$3K	Hold	27	–	–	﹤0.01%	888
2018 Q4	$2K	Hold	27	–	–	﹤0.01%	938
2018 Q3	$2K	Hold	27	–	–	﹤0.01%	991
2018 Q2	$3K	Hold	27	–	–	﹤0.01%	905
2018 Q1	$3K	Hold	27	–	–	﹤0.01%	878
2017 Q4	$3K	Buy	+27	New	+$3K	﹤0.01%	880
2017 Q1	–	Sell	-27	Closed	-$1K	–	265
2016 Q4	$1K	Buy	+27	New	+$1K	﹤0.01%	1010